Showing results (591-600 of 2,509) with videos related to
Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|June 7, 2024
Risk of Infection in Patients With Multiple Myeloma Treated With T-Cell Redirecting Approaches: A Call Out for CliniciansTommaso Lupia, Lorenzo Cani, Sara Bringhen, et al.Clinical Lymphoma, Myeloma & Leukemia|June 5, 2024
Breast Implant-Associated Anaplastic Large Cell Lymphoma: Where Hematology and Plastic Surgery MeetMaria Magdalena Joks, Krystian Czernikiewicz, Łukasz Mazurkiewicz, et al.Clinical Lymphoma, Myeloma & Leukemia|May 28, 2024
The Real-World Data on Patients With Cardiac Stage IIIb AL AmyloidosisYi Hong, Jinzhou Guo, Wencui Chen, et al.Clinical Lymphoma, Myeloma & Leukemia|November 16, 2023
Outcome of Multiple Myeloma Patients With Hepatitis B Surface Antigen: Korean Multiple Myeloma Working Party 2103 StudyJun Ho Yi, Jung Lim Lee, Yoo Jin Lee, et al.Clinical Lymphoma, Myeloma & Leukemia|September 23, 2023
Long-term Outcomes After Hematopoietic Cell Transplant in Peripheral T-Cell Lymphoma - The Oregon Health and Science University ExperienceDerek Galligan, Staci Williamson, Jessie Myers, et al.Clinical Lymphoma, Myeloma & Leukemia|September 21, 2023
Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden HospitalSu Li, Bhupinder Sharma, Siraj Yusuf, et al.Clinical Lymphoma, Myeloma & Leukemia|September 19, 2024
Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment Free Remission (TFR) in Chronic Myeloid Leukemia: Successful Achievement of TFR in More Than Two-Third of Patients in a Real-World PracticeAamer Aleem, Naila A Shaheen, Farjah Algahtani, et al.Clinical Lymphoma, Myeloma & Leukemia|October 5, 2024
Real World Data on Efficacy and Safety of EPOCH in T-Cell LymphomaRachael Straining, Francine Foss, Molly Schiffer, et al.Clinical Lymphoma, Myeloma & Leukemia|June 8, 2023
Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic MalignanciesManish R Patel, William Donnellan, Michael Byrne, et al.Clinical Lymphoma, Myeloma & Leukemia|June 4, 2023
Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective StudyTony Zibo Zhuang, Ashley McCook-Veal, Jeffrey Switchenko, et al.Pageof 251